Academic Field

Biological Sciences

Faculty Mentor Name

Dr. Paul Agris

Presentation Type

Oral Presentation

Abstract

Drug-resistant pathogens have risen in frequency and lethality. The development of antibiotics with new targets against multi-drug resistant organisms, such as Staphylococcus aureus, is imperative. The T-box regulatory mechanism is specific to Gram positive bacteria and many operons encoding essential genes required for bacterial growth are controlled by this process. The T-box Specifier loop is a novel target for antibacterial drug discovery as we hypothesize that a small compound bound to the Specifier loop will inhibit transcription of essential bacterial genes resulting in bacterial cell death or growth arrest. Using in silico analysis of the T-box Specifier loop, small compounds that are likely to disrupt T-box function were identified. Bacterial growth arrest studies identified three initial hit compounds, PKZ 1800, PKZ 0600, and PKZ 0700. Both PKZ 1800 and PKZ 0600 demonstrated greater antibacterial activity and were pursued for structure activity relationship studies (SAR). SAR was conducted with disk diffusion assays against S. aureus with structural analogs of two of our initial hits. Results revealed structural components of each hit compound necessary for antibacterial activity. Minimum Inhibitory Concentration (MIC) assays and Minimum Bactericidal Concentration (MBC) assays were conducted against S. aureus and the Gram-negative bacterium Escherichia coli for analogs that displayed antibacterial activity with disc diffusion assays. Data from first round SAR studies showed that PKZ 1800 analogs had greater Gram-positive specificity, making them the focus for second round SAR studies. Using the successful compound structures as a template, an additional in silico docking study was conducted on new potential analogs containing structures identified as essential to antibiotic activity. Top candidates of this docking simulation as well as other carefully selected analogs are currently undergoing testing using both MIC and MBC assays to further assess and refine structural determinants required for antibacterial activity.

Keywords

T-box, Specifier loop, antibacterial, and structure

Start Date

10-4-2015 4:15 PM

End Date

10-4-2015 5:30 PM

Location

Hartwell Hall 123

Share

COinS
 
Apr 10th, 4:15 PM Apr 10th, 5:30 PM

Structure Activity Relationship Studies of Small Molecules Directed Against the T-box Specifier Loop

Hartwell Hall 123

Drug-resistant pathogens have risen in frequency and lethality. The development of antibiotics with new targets against multi-drug resistant organisms, such as Staphylococcus aureus, is imperative. The T-box regulatory mechanism is specific to Gram positive bacteria and many operons encoding essential genes required for bacterial growth are controlled by this process. The T-box Specifier loop is a novel target for antibacterial drug discovery as we hypothesize that a small compound bound to the Specifier loop will inhibit transcription of essential bacterial genes resulting in bacterial cell death or growth arrest. Using in silico analysis of the T-box Specifier loop, small compounds that are likely to disrupt T-box function were identified. Bacterial growth arrest studies identified three initial hit compounds, PKZ 1800, PKZ 0600, and PKZ 0700. Both PKZ 1800 and PKZ 0600 demonstrated greater antibacterial activity and were pursued for structure activity relationship studies (SAR). SAR was conducted with disk diffusion assays against S. aureus with structural analogs of two of our initial hits. Results revealed structural components of each hit compound necessary for antibacterial activity. Minimum Inhibitory Concentration (MIC) assays and Minimum Bactericidal Concentration (MBC) assays were conducted against S. aureus and the Gram-negative bacterium Escherichia coli for analogs that displayed antibacterial activity with disc diffusion assays. Data from first round SAR studies showed that PKZ 1800 analogs had greater Gram-positive specificity, making them the focus for second round SAR studies. Using the successful compound structures as a template, an additional in silico docking study was conducted on new potential analogs containing structures identified as essential to antibiotic activity. Top candidates of this docking simulation as well as other carefully selected analogs are currently undergoing testing using both MIC and MBC assays to further assess and refine structural determinants required for antibacterial activity.